Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
22 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 March and 21 March 2024 Download
15 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 8 March and 14 March 2024 Download
12 Mar 2024 On business and financial situation ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies Download
08 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 March and 7 March 2024 Download
07 Mar 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives  Download

Pages

Date Title Description PDF
04 Oct 2018 Share capital increases and reductions Private placement capital increase addressed to institutional investors, excluding  preferential subscription rights Download
02 Oct 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2018 Download
24 Sep 2018 Others on business performance and financial information Updated information on business, financial position and risk factors Download
24 Sep 2018 Share capital increases and reductions Intention to raise gross proceeds by means of an offer addressed to institutional investors, excluding preferential subscription rights Download
26 Jul 2018 Información sobre resultados ROVI releases the 2018 first half results presentation Download

Pages